Overall, our findings indicate that USP10-ATMIN-LCK axis regulates NPC docetaxel sensitivity and promotes tumor growth, which may provide a potential therapeutic target for the management of NPC. This evidence concerns the gene LCK and nasopharyngeal carcinoma.